Imatinib mesylate both prevents and treats the arthritis induced by type II collagen antibody in mice

• KOYAMA Kensuke

  Department of Immunology, Faculty of Medicine, University of Yamanashi

• HATSUSHIKA Kyosuke

  Department of Immunology, Faculty of Medicine, University of Yamanashi

• ANDO Takashi

  Department of Immunology, Faculty of Medicine, University of Yamanashi

• SAKUMA Michitomo

  Department of Immunology, Faculty of Medicine, University of Yamanashi

• WAKO Masanori

  Department of Immunology, Faculty of Medicine, University of Yamanashi

• KATO Ryohei

  Department of Human Pathology, Faculty of Medicine, University of Yamanashi

• HARO Hirotaka

  Department of Orthopaedic Surgery, Faculty of Medicine, University of Yamanashi

• SUGIYAMA Hajime

  Department of Orthopaedic Surgery, Faculty of Medicine, University of Yamanashi

• HAMADA Yoshiki

  Department of Orthopaedic Surgery, Faculty of Medicine, University of Yamanashi

• OGAWA Hideoki

  Atopy Research Center, Juntendo University School of Medicine

• NAKAO Atsuhito

  Department of Immunology, Faculty of Medicine, University of Yamanashi

収録刊行物

• Modern rheumatology

  Modern rheumatology 17 (4), 306-310, 2007-08-01

キーワード

• Anti-collagen type II antibody-induced arthritis (CAIA )
• Imatinib mesylate
• Rheumatoid arthritis

詳細情報

• CRID: 1571698600397312128
• NII論文ID: 10019865098
• NII書誌ID: AA1157187X
• ISSN: 14397595
• Web Site: https://search.jamas.or.jp/link/ui/2008080625
• 本文言語コード: en
• データソース種別:
  • CiNii Articles